KRAS-mutant colon cancer | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

96,236 results for “KRAS-mutant colon cancer”

Trials

View all 77693 →

Multicentric Database for KRAS Mutant Pancreatic Cancer

1,000 participants · First posted Apr 30, 2026

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

665 participants · First posted Apr 8, 2025

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

15 participants · First posted Sep 24, 2018

Drugs

View all 2536 →

colon cancer therapy (NCI)

Pooled mutant-KRAS peptide vaccine (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

mRNA vaccine targeting KRAS mutant antigens (cancer)

Organizations

View all 1106 →

SWEET CHEEKS COLON CARE PTY LTD

Australia

CENTER WEST CANCER

United States

Fujian Cancer Hospital (Fujian Cancer Institute, Fujian Cancer Prevention and Treatment Center)

China

News

View all 14901 →

SEED Therapeutics Receives FDA Clearance for First-in-Human Trial of RBM39 Degrader ST-01156

SEED Therapeutics Receives China NMPA Clearance for ST-01156 Molecular Glue Degrader in Rare Cancer Trial

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Page 1 of 9624